Karlsson MO - Search Results

1

Population pharmacokinetics of edoxaban and its main metabolite in a dedicated renal impairment study.

Jönsson S, Simonsson US, Miller R, Karlsson MO. Jönsson S, et al. Among authors: karlsson mo. J Clin Pharmacol. 2015 Nov;55(11):1268-79. doi: 10.1002/jcph.541. Epub 2015 Jun 30. J Clin Pharmacol. 2015. PMID: 25966665 Clinical Trial.

2

A comparison between the semisimultaneous and the stable isotope techniques for bioavailability estimation of terbutaline in humans.

Bredberg U, Karlsson MO, Borgström L. Bredberg U, et al. Among authors: karlsson mo. Clin Pharmacol Ther. 1992 Sep;52(3):239-48. doi: 10.1038/clpt.1992.136. Clin Pharmacol Ther. 1992. PMID: 1526079 Clinical Trial.

3

Pharmacokinetics of oral noscapine.

Karlsson MO, Dahlström B, Eckernäs SA, Johansson M, Alm AT. Karlsson MO, et al. Eur J Clin Pharmacol. 1990;39(3):275-9. doi: 10.1007/BF00315110. Eur J Clin Pharmacol. 1990. PMID: 2257866 Clinical Trial.

4

Toxicokinetics of lead in lactating and nonlactating mice.

Hallén IP, Jönsson S, Karlsson MO, Oskarsson A. Hallén IP, et al. Among authors: karlsson mo. Toxicol Appl Pharmacol. 1996 Feb;136(2):342-7. doi: 10.1006/taap.1996.0041. Toxicol Appl Pharmacol. 1996. PMID: 8619242

5

Kinetic observations in neonatal mice exposed to lead via milk.

Palminger Hallén I, Jönsson S, Karlsson MO, Oskarsson A. Palminger Hallén I, et al. Among authors: karlsson mo. Toxicol Appl Pharmacol. 1996 Sep;140(1):13-8. doi: 10.1006/taap.1996.0192. Toxicol Appl Pharmacol. 1996. PMID: 8806865

6

Concentration-effect relations of glibenclamide and its active metabolites in man: modelling of pharmacokinetics and pharmacodynamics.

Rydberg T, Jönsson A, Karlsson MO, Melander A. Rydberg T, et al. Among authors: karlsson mo. Br J Clin Pharmacol. 1997 Apr;43(4):373-81. doi: 10.1046/j.1365-2125.1997.00571.x. Br J Clin Pharmacol. 1997. PMID: 9146849 Free PMC article. Clinical Trial.

7

A general model for time-dissociated pharmacokinetic-pharmacodynamic relationship exemplified by paclitaxel myelosuppression.

Karlsson MO, Molnar V, Bergh J, Freijs A, Larsson R. Karlsson MO, et al. Clin Pharmacol Ther. 1998 Jan;63(1):11-25. doi: 10.1016/S0009-9236(98)90117-5. Clin Pharmacol Ther. 1998. PMID: 9465838

8

The population pharmacokinetics of recombinant- and urinary-human follicle stimulating hormone in women.

Karlsson MO, Wade JR, Loumaye E, Munafo A. Karlsson MO, et al. Br J Clin Pharmacol. 1998 Jan;45(1):13-20. doi: 10.1046/j.1365-2125.1998.00644.x. Br J Clin Pharmacol. 1998. PMID: 9489588 Free PMC article. Clinical Trial.

9

Artemisinin population pharmacokinetics in children and adults with uncomplicated falciparum malaria.

Sidhu JS, Ashton M, Huong NV, Hai TN, Karlsson MO, Sy ND, Jonsson EN, Cong LD. Sidhu JS, et al. Among authors: karlsson mo. Br J Clin Pharmacol. 1998 Apr;45(4):347-54. doi: 10.1046/j.1365-2125.1998.t01-1-00686.x. Br J Clin Pharmacol. 1998. PMID: 9578181 Free PMC article.

10

Kinetics of methylmercury and inorganic mercury in lactating and nonlactating mice.

Sundberg J, Jönsson S, Karlsson MO, Hallén IP, Oskarsson A. Sundberg J, et al. Among authors: karlsson mo. Toxicol Appl Pharmacol. 1998 Aug;151(2):319-29. doi: 10.1006/taap.1998.8456. Toxicol Appl Pharmacol. 1998. PMID: 9707508

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

421 results

Search Page